CAS 210110-90-0
:3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3R,4R,5S)-
- 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3R,4R,5S)-
- 3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, hydrochloride, (2R,3R,4R,5S)-
- Miglustat HCl
- Miglustat hydrochloride
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
N-(n-Butyl)-1-deoxynojirimycin hydrochloride
CAS:N-(n-Butyl)-1-deoxynojirimycin hydrochlorideFormula:C10H21NO4·ClHPurity:>99%Color and Shape:Solid-CrystalsMolecular weight:255.73898(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride
CAS:(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochlorideFormula:C10H21NO4·ClHPurity:98%Color and Shape:SolidMolecular weight:255.73898Miglustat hydrochloride
CAS:Miglustat hydrochlorideFormula:C10H22ClNO4Purity:99.5%Molecular weight:255.742Miglustat HCl
CAS:Formula:C10H21NO4·HClColor and Shape:White To Off-White SolidMolecular weight:219.28 36.46Miglustat hydrochloride
CAS:Formula:C10H22ClNO4Purity:98%Color and Shape:SolidMolecular weight:255.7390N-Butyldeoxynojirimycin Hydrochloride
CAS:Controlled ProductApplications An inhibitor of a-glucosidase 1 as well as being an inhibitor of HIV cytopathicity. N-Butyldeoxynojirimycin has recently been used to retard lipid storage in the central nervous system of an animal model of Tay-Sachs disease.1-Deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man.
References Hettkamp, H., et al.: Eur. J. Biochem., 142, 85 (1984), Szumilo, T., et al.: Arch. Biochem. Biophys., 247, 261 (1986), Fleet, G.W.J., et al.: FEBS Letters, 237, Number 1,2, 128 (1988), Kolter, T., et al.: Angew. Chem. Int. Ed. Engl., 36, 1955 (1997),Formula:C10H21NO4·ClHColor and Shape:NeatMolecular weight:255.74Miglustat HCl
CAS:(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochlorideFormula:C10H22ClNO4Purity:98%Molecular weight:255.74N-Butyldeoxynojirimycin hydrochloride
CAS:Competitive inhibitor of ceramide-glycosyltransferase used for substrate reduction therapy in lysosomal storage disorders. It inhibits glucosylceramide synthase, which catalyses the initial step in glycosphingolipid biosynthetic pathway. This compound delays the onset of symptoms in type 1 Gaucher disease, Sandhoff disease and Tay-Sachs disease. It also reduces brain abnormalities in mucolipidosis type IV.
Formula:C10H21NO4•HClPurity:Min. 95%Color and Shape:PowderMolecular weight:255.74 g/molMiglustat hydrochloride
CAS:Miglustat hydrochloride (N-Butyldeoxynojirimycin hydrochloride) is an inhibitor of glucosylceramide synthase and can be used for studies about Type I GaucherFormula:C10H22ClNO4Purity:99.85%Color and Shape:SolidMolecular weight:255.74









